DSP Healthcare Fund - IDCW - Regular Plan

Other Plans and Options
  • 0.93 %Nav, as on 12-08-2025

  • Previous Nav

  • Net Change on 12-08-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
DSP Healthcare Fund - Regular Plan - IDCW -0.20 8.09 3.80 23.87 19.34 22.67
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
DSP Healthcare Fund - Regular Plan - IDCW Nov 30, 2018 3.80 23.87 19.34 1.93 3,190.15
NIPPON INDIA PHARMA FUND - IDCW Option Jun 05, 2004 1.99 22.20 18.21 1.80 8,736.57
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option Jul 13, 2018 8.55 27.29 21.00 1.89 6,103.96
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jul 03, 1999 10.36 26.30 19.98 1.93 4,026.55
Mirae Asset Healthcare Fund Regular IDCW Jul 02, 2018 3.80 20.88 18.37 1.93 2,908.21
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 3.32 23.14 18.55 2.11 1,339

Fund Holdings as on 31-July-2025

  • Cipla Limited

  • Sun Pharmaceutical Industries Limited

  • IPCA Laboratories Limited

  • Cohance Lifesciences Limited

  • Laurus Labs Limited

  • Gland Pharma Limited

  • Apollo Hospitals Enterprise Limited

  • Illumina Inc

  • Alembic Pharmaceuticals Limited

  • Sai Life Sciences Limited

  • Globus Medical Inc

  • Pfizer Limited

  • Kovai Medical Center and Hospital Limited

  • Indoco Remedies Limited

  • Vijaya Diagnostic Centre Limited

  • Procter & Gamble Health Limited

  • Concord Biotech Limited

  • Intuitive Surgical Inc

  • TREPS / Reverse Repo Investments

  • Emcure Pharmaceuticals Limited

  • Unichem Laboratories Limited

  • ICICI Lombard General Insurance Company Limited

  • Aarti Drugs Limited

  • Abbott Laboratories

  • Thyrocare Technologies Limited

  • Alkem Laboratories Limited

  • Global X Funds - Global X Genomics & Biotechnology ETF

  • Medplus Health Services Limited

  • Jupiter Life Line Hospitals Limited

  • Laxmi Dental Limited

  • Grail Inc

  • Net Receivables/Payables

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Insurance

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

Most Recent Dividend

  • 28/02/2025

  • 01/03/2024

  • 03/03/2023

  • 04/03/2022

  • 26/03/2021

  • Cash

  • Equity

  • MFU

View More

About DSP Healthcare Fund

Scheme Analysis

DSP Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to DSP Mutual Fund. It was launched on 30-Nov-2018 and currently has an AUM of ₹3,190.15 crore. DSP Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of DSP Healthcare Fund ended up ₹0.23(0.93%)yesterday to ₹24.757.

Among its top 3 holdings the fund has exposure to Cipla Limited, and

The DSP Healthcare Fund is managed by Chirag Dagli .

Fund House Contact

The Ruby, 25th Floor, 29, Senapati Bapat Marg, Dadar (West) Mumbai - 400 028

+91 (22) 66578000
service@dspim.com
+91 (22) 66578181